Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

818 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A significant proportion of patients with chronic hepatitis B who are candidates for antiviral treatment are untreated: A region-wide survey in Italy.
Giannini EG, Torre F, Basso M, Feasi M, Boni S, Grasso A, De Leo P, Dodi F, Marazzi MG, Azzola E, Bartolacci V, Percario G, Beltrame A, Borro P, Savarino V, Picciotto A; Ligurian Hepatitis B Virus Study Group. Giannini EG, et al. Among authors: basso m. J Clin Gastroenterol. 2009 Nov-Dec;43(10):1001-7. doi: 10.1097/MCG.0b013e31818e876f. J Clin Gastroenterol. 2009. PMID: 19318981
Kinetics of soluble tumour necrosis factor (TNF)-alpha receptors and cytokines in the early phase of treatment for chronic hepatitis C: comparison between interferon (IFN)-alpha alone, IFN-alpha plus amantadine or plus ribavirin.
Torre F, Rossol S, Pelli N, Basso M, Delfino A, Picciotto A. Torre F, et al. Among authors: basso m. Clin Exp Immunol. 2004 Jun;136(3):507-12. doi: 10.1111/j.1365-2249.2004.02476.x. Clin Exp Immunol. 2004. PMID: 15147353 Free PMC article.
A randomized trial of pegylated-interferon-alpha2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirin.
Ciancio A, Picciotto A, Giordanino C, Smedile A, Tabone M, Manca A, Marenco G, Garbagnoli P, Andreoni M, Cariti G, Calleri G, Sartori M, Cusumano S, Grasso A, Rizzi R, Gallo M, Basso M, Anselmo M, Percario G, Ciccone G, Rizzetto M, Saracco G. Ciancio A, et al. Among authors: basso m. Aliment Pharmacol Ther. 2006 Oct 1;24(7):1079-86. doi: 10.1111/j.1365-2036.2006.03098.x. Aliment Pharmacol Ther. 2006. PMID: 16984502 Free article. Clinical Trial.
Soluble apoptosis molecules in primary biliary cirrhosis: analysis and commitment of the Fas and tumour necrosis factor-related apoptosis-inducing ligand systems in comparison with chronic hepatitis C.
Pelli N, Floreani A, Torre F, Delfino A, Baragiotta A, Contini P, Basso M, Picciotto A. Pelli N, et al. Among authors: basso m. Clin Exp Immunol. 2007 Apr;148(1):85-9. doi: 10.1111/j.1365-2249.2006.03293.x. Clin Exp Immunol. 2007. PMID: 17302732 Free PMC article.
818 results